GLP-1 receptor agonists like semaglutide influence brain reward pathways that regulate eating and substance use, which may explain reductions in alcohol consumption and binge drinking observed in research and patient reports
The DAC modification allows it to bind to albumin in the blood, dramatically extending its half-life to a matter of days rather than minutes or hours
In summary, there are evidence, that treatment with GLP-1RAs may prove useful in the treatment of depressive disorders, however, the number of reliable clinical reports concerning this matter remains very low at this point
And while GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have taken the weight loss world by storm, here's what most most people are missing: these medications work significantly better when your hormones are also being addressed
We often see that the effect feels clearer when you: keep track of calories avoid overeating choose smaller but more nutrient-dense portions keep a stable protein intake eat regularly rather than spontaneously Conversely, large meals, very unhealthy food or unstructured eating can drown out the medication for some users
Clin Liver Dis (2005) 9:6781